alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EXHIBIT 12


                                                   Three months ended March 31,
                                                      1999             1998
                                                  ------------     ------------

Net loss                                          $ (8,416,571)    $ (9,674,898)
Interest expense                                       482,056           19,931
Amortization of debt costs                             210,043          263,720
Income tax                                                  --               --
                                                  ------------     ------------

Loss before fixed charges                           (7,724,472)      (9,391,247)

Fixed charges                                          692,099          283,651

Ratio of net loss before fixed charges to
  fixed charges                                          (11.2)           (33.1)

Deficiency of earnings to cover fixed
  charges                                         $ (8,416,571)    $ (9,674,898)
EXHIBIT 32.b



CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of American Affordable Housing II Limited Partnership (the "Partnership") on Form 10-Q for the period ended September 30, 2010 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Marc N. Teal, Principal Financial Officer of the general partner of the general partner of the Partnership's general partner, C&M Management Inc., certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge, after due inquiry:



|(1) | The Report fully complies with the requirements of section 13(a)-15 or 15(d)-15 of the Securities and Exchange Act of 1934; and                         
|--- | --------------------------------------------------------------------------------------------------------------------------------------------------------
|    |                                                                                                                                                         
|(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Partnership.



|                  |     |                            
|----------------- | --- | ---------------------------
|Date:             |     |                            
|November 15, 2010 | By: | /s/ Marc N. Teal           
|                  |     |                            
|                  |     | Marc N. Teal               
|                  |     | Principal Financial Officer

A signed original of this written statement required by Section 906, or other

document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Fund and will be retained by the Fund and furnished to the Securities and Exchange Commission or its staff upon request.
I 

118TH CONGRESS 

1ST SESSION H. R. 787 

To require executive agencies to reduce cost-sharing requirements for certain 

grants with certain nonprofit organizations 25 percent, and for other 

purposes. 

IN THE HOUSE OF REPRESENTATIVES 

FEBRUARY 2, 2023 

Mrs. GONZA ́LEZ-COLO ́N (for herself, Ms. VELA ́ZQUEZ, Mr. SABLAN, Mrs. 

RADEWAGEN, and Mr. SOTO) introduced the following bill; which was referred to the Committee on Oversight and Accountability 

A BILL 

To require executive agencies to reduce cost-sharing requirements for certain grants with certain nonprofit organizations 25 percent, and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Empowering Non5 profits Act’’. 

6 SEC. 2. REDUCTION OF COST-SHARING REQUIREMENTS 

7 FOR GRANTS. 

8 (a) REDUCTION OF COST-SHARING REQUIRE9 MENT.—Beginning on the date of the enactment of this 


pbinns on DSKJLVW7X2PROD with $$_JOB
2 

•HR 787 IH

1 Act and ending 5 years thereafter, the head of an execu2 tive agency shall reduce any cost-sharing requirement 25 

3 percent for an eligible nonprofit organization for grants 

4 made directly to that organization. 

5 (b) DEFINITIONS.—In this section: 

6 (1) ELIGIBLE NONPROFIT ORGANIZATION.—The 

7 term ‘‘eligible nonprofit organization’’ means a non8 profit organization that is located in a State with 

9 more than 20 percent of individuals living below the 

10 Federal poverty line. 

11 (2) EXECUTIVE AGENCY.—The term ‘‘executive 

12 agency’’ has the meaning given in section 133 of 

13 title 41, United States Code. 

14 (3) NONPROFIT ORGANIZATION.—The term 

15 ‘‘nonprofit organization’’ means an organization that 

16 is described in section 501(c)(3) of the Internal Rev17 enue Code of 1968 and exempt from taxation under 

18 section 501(a) of such Code. 

19 (4) STATE.—The term ‘‘State’’ means each of 

20 the several States, the District of Columbia, each 

21 commonwealth, territory, or possession of the United 

22 States, and each federally recognized Tribe. 

Æ 


pbinns on DSKJLVW7X2PROD with $$_JOB
Editorial Note on Part 870
Editorial Note: Nomenclature changes to part 870 appear at 73 FR 35341, June 23, 2008.

§ 870.3800 Annuloplasty ring. ( a ) *Identification.* An annuloplasty ring is a rigid or flexible ring implanted around the mitral or tricuspid heart valve for reconstructive treatment of valvular insufficiency.
( b ) *Classification.* Class II (special controls). The special control for this device is the FDA guidance document entitled “Guidance for Annuloplasty Rings 510(k) Submissions.”
[45 FR 7907, Feb. 5, 1980, as amended at 52 FR 17736, May 11, 1987; 66 FR 18542, Apr. 10, 2001]
Editorial Note on Part 888
Editorial Note: Nomenclature changes to part 888 appear at 73 FR 35341, June 23, 2008.

§ 888.4230 Cement ventilation tube. ( a ) *Identification.* A cement ventilation tube is a tube-like device usually made of plastic intended to be inserted into a surgical cavity to allow the release of air or fluid from the cavity as it is being filled with bone cement (§ 888.3027).
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter, subject to the limitations in § 888.9.
[52 FR 33702, Sept. 4, 1987, as amended at 53 FR 52954, Dec. 29, 1988; 59 FR 63014, Dec. 7, 1994; 66 FR 38815, July 25, 2001]
# C_2014431EN.01003701.xml

| 1.12.2014 | EN | Official Journal of the European Union | C 431/37 |
| --- | --- | --- | --- |

1.12.2014

EN

Official Journal of the European Union

C 431/37

---

Action brought on 19 September 2014 — Sony Computer Entertainment Europe v OHIM — Marpefa (Vieta)

(Case T-690/14)

(2014/C 431/60)

Language in which the application was lodged: English

Parties

Parties

Applicant: Sony Computer Entertainment Europe Ltd (London, United Kingdom) (represented by: S. Malynicz, Barrister)

Applicant:

Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs) (OHIM)

Defendant:

Other party to the proceedings before the Board of Appeal: Marpefa, SL (Barcelona, Spain)

Other party to the proceedings before the Board of Appeal:

Details of the proceedings before OHIM

Details of the proceedings before OHIM

Applicant: Applicant

Applicant:

Trade mark at issue: Community trade mark No 1 7 90  674

Trade mark at issue:

Procedure before OHIM: Proceedings for a declaration of invalidity

Procedure before OHIM

Contested decision: Decision of the Second Board of Appeal of OHIM of 2 July 2014 in Case R 2100/2013-2

Contested decision

Form of order sought

Form of order sought

The applicant claims that the Court should:

| — | annul the contested decision; |
| --- | --- |

—

annul the contested decision;

| — | order OHIM and the other party to the proceedings before the Board of Appeal to pay the costs. |
| --- | --- |

—

order OHIM and the other party to the proceedings before the Board of Appeal to pay the costs.

Pleas in law

Pleas in law

| — | Infringement of Article 15(1) Regulation No 207/2009; |
| --- | --- |

—

Infringement of Article 15(1) Regulation No 207/2009;

| — | Infringement of Article 15(1)(a) Regulation No 207/2009; |
| --- | --- |

—

Infringement of Article 15(1)(a) Regulation No 207/2009;

| — | Infringement of Article 51(2) Regulation No 207/2009. |
| --- | --- |

—

Infringement of Article 51(2) Regulation No 207/2009.

---
Editorial Note on Part 870
Editorial Note: Nomenclature changes to part 870 appear at 73 FR 35341, June 23, 2008.

§ 870.2910 Radiofrequency physiological signal transmitter and receiver. ( a ) *Identification.* A radiofrequency physiological signal transmitter and receiver is a device used to condition a physiological signal so that it can be transmitted via radiofrequency from one location to another, e.g., a central monitoring station. The received signal is reconditioned by the device into its original format so that it can be displayed.
( b ) *Classification.* Class II (performance standards).
§ 630.1 Purpose and scope. ( a ) *What is the purpose of subparts A , B , and C of this part* ? The purpose of these subparts, together with §§ 610.40 and 610.41 of this chapter, is to provide certain minimum criteria for each donation of blood and blood components, for: ( 1 ) Determining the eligibility of a donor of blood and blood components;
( 2 ) Determining the suitability of the donation of blood and blood components; and
( 3 ) Notifying a donor who is deferred from donation.
( b ) *Who must comply with subparts A , B , and C of this part* ? Blood establishments that manufacture blood and blood components, as defined in § 630.3(a) and (b), must comply with subparts A, B, and C of this part.
Editorial Note on Part 886
Editorial Note: Nomenclature changes to part 886 appear at 73 FR 35341, June 23, 2008.

§ 886.1375 Bagolini lens. ( a ) *Identification.* A Bagolini lens is a device that consists of a plane lens containing almost imperceptible striations that do not obscure visualization of objects. The device is placed in a trial frame and intended to determine harmonious/anomalous retinal correspondence (a condition in which corresponding points on the retina have the same directional values).
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter, subject to the limitations in § 886.9. The device is also exempt from the current good manufacturing practice requirements of the quality system regulation in part 820 of this chapter, with the exception of § 820.180, with respect to general requirements concerning records, and § 820.198, with respect to complaint files.
[52 FR 33355, Sept. 2, 1987, as amended at 53 FR 35604, Sept. 14, 1988; 66 FR 38810, July 25, 2001]
#### § 900.5 Evaluation.

FDA shall evaluate annually the performance of each accreditation body. Such evaluation shall include an assessment of the reports of FDA or State inspections of facilities accredited by the body as well as any additional information deemed relevant by FDA that has been provided by the accreditation body or other sources or has been required by FDA as part of its oversight initiatives. The evaluation shall include a determination of whether there are major deficiencies in the accreditation body's performance that, if not corrected, would warrant withdrawal of the approval of the accreditation body under the provisions of § 900.6.
# C_2014159EN.01003102.xml

| 26.5.2014 | EN | Official Journal of the European Union | C 159/31 |
| --- | --- | --- | --- |

26.5.2014

EN

Official Journal of the European Union

C 159/31

---

Action brought on 5 March 2014 — Pavlides v Commission and ECB

(Case T-150/14)

2014/C 159/42

Language of the case: English

Parties

Parties

Applicant: Constantinos Pavlides (Nicosia, Cyprus) (represented by: C. Paschalides, Solicitor, and A. Paschalides, lawyer)

Applicant:

Defendants: European Central Bank and European Commission

Defendants:

Form of order sought

Form of order sought

The applicant claims that the Court should:

| — | Order the defendants to compensate the applicant under Article 268 of the TFEU. |
| --- | --- |

—

Order the defendants to compensate the applicant under Article 268 of the TFEU.

Pleas in law and main arguments

Pleas in law and main arguments

The applicant contends that the defendants caused him to be deprived of the money in his account because they induced the premature imposition of a bail-in tool on his deposit with his bank as part of the conditionality attached to financial assistance provided to Cyprus on 26 April 2013 pursuant to Article 13 of the European Stability Mechanism Treaty of 2012 as follows: a) the defendants ‘manifestly and gravely disregarded the limits’ on their power as EU institutions under Article 136(3) of the TFEU; b) unlawfully surrendered effective control of their functions as EU institutions; c) induced the premature passing of a bail-in tool on deposits with Bank of Cyprus and Cyprus Popular Bank which had not been passed into the EU law; d) induced restrictions on the movement of money preventing deposit holders from withdrawing and/or transferring their funds to safer institutions; and e) did so in breach of the principles of legal certainty, equality and human rights.

---
Editorial Note on Part 874
Editorial Note: Nomenclature changes to part 874 appear at 73 FR 35341, June 23, 2008.

§ 874.3695 Mandibular implant facial prosthesis. ( a ) *Identification.* A mandibular implant facial prosthesis is a device that is intended to be implanted for use in the functional reconstruction of mandibular deficits. The device is made of materials such as stainless steel, tantalum, titanium, cobalt-chromium based alloy, polytetrafluoroethylene, silicone elastomer, polyethylene, polyurethane, or polytetrafluoroethylene with carbon fibers composite.
( b ) *Classification.* Class II.
Editorial Note on Part 868
Editorial Note: Nomenclature changes to part 868 appear at 73 FR 35341, June 23, 2008.

§ 868.1870 Gas volume calibrator. ( a ) *Identification.* A gas volume calibrator is a device that is intended for medical purposes and that is used to calibrate the output of gas volume measurement instruments by delivering a known gas volume.
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 868.9.
[47 FR 31142, July 16, 1982, as amended at 61 FR 1119, Jan. 16, 1996; 66 FR 38793, July 25, 2001]
§ 1.1055-3 Basis of real property held subject to liabilities under a redeemable ground rent. ( a ) *In general.* The provisions of section 1055(a) and paragraph (a) of § 1.1055-1 are applicable in determining the basis of real property held on or after April 11, 1963, in any case where the property at the time of acquisition was subject to liabilities under a redeemable ground rent. (See section 1055(b)(2).) Thus, if on or after April 11, 1963, a taxpayer holds real property which was subject to liabilities under a redeemable ground rent at the time he acquired it, the basis of such property in the hands of such taxpayer, regardless of when the property was acquired, will include the redeemable ground rent in the same manner as if it were a mortgage in an amount equal to the redemption price of such ground rent. Likewise, if on or after April 11, 1963, a taxpayer holds real property which was subject to liabilities under a redeemable ground rent at the time he acquired it and which has a substituted basis in his hands, the basis of the property in the hands of the taxpayer's predecessor in interest is to be determined by treating the redeemable ground rent in the same manner as a mortgage in an amount equal to the redemption price of such ground rent.
( b ) *Illustrations.* The provisions of this section may be illustrated by the following examples:
Example 1. On April 11, 1963, taxpayer A held residential property which he acquired on January 15, 1963, for a purchase price of $10,000 and which, at the time he acquired it, was subject to a ground rent redeemable for a redemption price of $1,600. A's basis for the property includes the purchase price ($10,000) plus the redeemable ground rent in the same manner as if it were a mortgage for $1,600.
Example 2. In 1962, taxpayer X, a corporation, acquired real property subject to a redeemable ground rent in a transfer to which section 351 (relating to transfer of property to corporation controlled by transferor) applied and in which the basis of the property to X was the transferor's basis. X still held the property on April 11, 1963. The transferor's basis in the property is to be determined by treating the redeemable ground rent to which it was subject in the transferor's hands as if it were a mortgage.
[T.D. 6821, 30 FR 6217, May 4, 1965]
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Defense

###### Office of the Secretary

# AGENCY:

Department of Defense (DoD).

# ACTION:

Notice of closed meeting.

# SUMMARY:

Pursuant to the provisions of section 10 of Public Law 92-463, the Federal Advisory Committee Act, notice is hereby given that the Department of Defense Wage Committee will meet on April 6, 2010. The meeting is closed to the public.

# DATES:

The meeting will be held on Tuesday, April 6, 2010, at 10 a.m.

# ADDRESSES:

The meeting will be held at 1400 Key Boulevard, Level A, Room A101, Rosslyn, Virginia 22209.

# FOR FURTHER INFORMATION CONTACT:

Additional information concerning the meetings may be obtained by writing to the Chairman, Department of Defense Wage Committee, 4000 Defense Pentagon, Washington, DC 20301-4000.

# SUPPLEMENTARY INFORMATION:

Under the provisions of section 10(d) of Public Law 92-463, the Department of Defense has determined that the meeting meets the criteria to close meetings to the public because the matters to be considered are related to internal rules and practices of the Department of Defense and the detailed wage data to be considered were obtained from officials of private establishments with a guarantee that the data will be held in confidence.

## Written Statements

                    Members of the public who may wish to do so are invited to submit material in writing to the chairman (                    *see***FOR FURTHER INFORMATION CONTACT**                    ) concerning matters believed to be deserving of the Committee's attention.                

Dated: March 4, 2010.

Mitchell S. Bryman,

Alternate OSD Federal Register Liaison Officer, Department of Defense.

[FR Doc. 2010-5099 Filed 3-9-10; 8:45 am]

BILLING CODE 5001-06-P
Editorial Note on Part 882
Editorial Note: Nomenclature changes to part 882 appear at 73 FR 35341, June 23, 2008.

§ 882.5500 Lesion temperature monitor. ( a ) *Identification.* A lesion temperature monitor is a device used to monitor the tissue temperature at the site where a lesion (tissue destruction) is to be made when a surgeon uses a radiofrequency (RF) lesion generator and probe.
( b ) *Classification.* Class II (performance standards).
# C_2014388EN.01001901.xml

| 3.11.2014 | EN | Official Journal of the European Union | C 388/19 |
| --- | --- | --- | --- |

3.11.2014

EN

Official Journal of the European Union

C 388/19

---

Action brought on 28 July 2014 — ABZ Aardbeien Uit Zaad Holding a.o. v Parliament and Council

(Case T-560/14)

2014/C 388/23

Language of the case: English

Parties

Parties

Applicants: ABZ Aardbeien Uit Zaad Holding BV (Hoorn NH, Netherlands); Agriom BV (Aalsmeer, Netherlands); Agrisemen BV (Ellewoutsdijk, Netherlands); Anthura BV (Bleiswijk, Netherlands); Barenbrug Holding BV (Oosterhout, Netherlands); De Bolster BV (Epe, Netherlands); Evanthia BV (Hoek van Holland, Netherlands); Gebr. Vletter & Den Haan VOF (Rijnsburg, Netherlands); Hilverda Kooij BV (Aalsmeer, Netherlands); Holland-Select BV (Andijk, Netherlands); Könst Breeding BV (Nieuwveen, Netherlands); Koninklijke Van Zanten BV (Hillegom, Netherlands); Kweek- en Researchbedrijf Agirco BV (Emmeloord, Netherlands); Kwekerij de Wester-Bouwing BV (Rossum, Netherlands); Limgroup BV (Horst aan de Maas, Netherlands); and Ontwikkelingsmaatschappij Het Idee BV (Amsterdam, Netherlands) (represented by: P. de Jong, P. Vlaemminck and B. Van Vooren, lawyers)

Applicants:

Defendants: Council of the European Union and European Parliament

Defendants:

Form of order sought

Form of order sought

The applicants claim that the Court should:

| — | declare the action in annulment admissible; |
| --- | --- |

—

declare the action in annulment admissible;

| — | annul Regulation (EU) No 511/2014 of the European Parliament and of the Council of 16 April 2014 on compliance measures for users from the Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from their Utilisation in the Union (OJ L 150, p. 59); and |
| --- | --- |

—

annul Regulation (EU) No 511/2014 of the European Parliament and of the Council of 16 April 2014 on compliance measures for users from the Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from their Utilisation in the Union (OJ L 150, p. 59); and

| — | order the European Parliament and the Council to pay the costs. |
| --- | --- |

—

order the European Parliament and the Council to pay the costs.

Pleas in law and main arguments

Pleas in law and main arguments

In support of the action, the applicant relies on five pleas in law which are essentially identical or similar to those relied on in Case T-559/14 Ackermann Saatzucht a.o. v Parliament and Council.

Ackermann Saatzucht a.o. v Parliament and Council.

---
# C_2015155EN.01003904.xml

| 11.5.2015 | EN | Official Journal of the European Union | C 155/39 |
| --- | --- | --- | --- |

11.5.2015

EN

Official Journal of the European Union

C 155/39

---

Order of the General Court of 16 March 2015 — Sun Alloys Europe v Commission

(Case T-304/14) (1)

1

(2015/C 155/53)

Language of the case: German

The President of the Third Chamber has ordered that the case be removed from the register.

---

(1)  OJ C 223, 14.7.2014.

1

---